Primary |
Diabetes Mellitus |
71.4% |
Product Used For Unknown Indication |
14.3% |
Thrombosis Prophylaxis |
14.3% |
|
Respiratory Distress |
100.0% |
|
Secondary |
Drug Use For Unknown Indication |
19.5% |
Product Used For Unknown Indication |
15.0% |
Pain |
11.3% |
Anaesthesia |
6.4% |
Back Pain |
6.3% |
Hypertension |
6.1% |
Prophylaxis |
6.0% |
Rheumatoid Arthritis |
4.8% |
Procedural Pain |
3.3% |
Surgery |
3.3% |
Hiv Infection |
2.8% |
Suicide Attempt |
2.5% |
Sciatica |
2.1% |
Thrombosis Prophylaxis |
1.9% |
Parkinson's Disease |
1.7% |
Induction Of Anaesthesia |
1.5% |
Type 2 Diabetes Mellitus |
1.5% |
Migraine |
1.3% |
Non-hodgkin's Lymphoma |
1.3% |
Obesity |
1.3% |
|
Neutropenia |
10.1% |
Renal Failure Acute |
8.3% |
Vomiting |
7.3% |
Renal Failure |
6.4% |
Weight Decreased |
6.4% |
Haemorrhage |
5.5% |
Toxic Epidermal Necrolysis |
5.5% |
Toxic Skin Eruption |
5.5% |
Acute Generalised Exanthematous Pustulosis |
4.6% |
Cytolytic Hepatitis |
4.6% |
Urticaria |
4.6% |
Dermo-hypodermitis |
3.7% |
Renal Tubular Necrosis |
3.7% |
Respiratory Disorder |
3.7% |
Sepsis |
3.7% |
Thrombocytopenia |
3.7% |
Torsade De Pointes |
3.7% |
Tremor |
3.7% |
Anaphylactic Shock |
2.8% |
Gastrointestinal Haemorrhage |
2.8% |
|
Concomitant |
Product Used For Unknown Indication |
40.9% |
Drug Use For Unknown Indication |
13.9% |
Pain |
10.6% |
Rheumatoid Arthritis |
9.4% |
Hypertension |
3.0% |
Premedication |
3.0% |
Depression |
2.3% |
Cholecystitis |
1.8% |
Chronic Obstructive Pulmonary Disease |
1.8% |
Back Pain |
1.6% |
Osteoporosis |
1.6% |
Thrombosis Prophylaxis |
1.5% |
Breast Cancer Metastatic |
1.2% |
Prophylaxis |
1.2% |
Sciatica |
1.2% |
General Anaesthesia |
1.1% |
Spondylitis |
1.1% |
Arthralgia |
1.0% |
Sleep Disorder |
1.0% |
Diabetes Mellitus |
0.9% |
|
Renal Failure Acute |
14.1% |
Vomiting |
12.9% |
Weight Increased |
10.6% |
Neutropenia |
7.1% |
Cholestasis |
4.7% |
Pain In Extremity |
4.7% |
Septic Shock |
4.7% |
Sinusitis |
4.7% |
Thrombocytopenia |
4.7% |
Bacterial Sepsis |
3.5% |
Nausea |
3.5% |
Urticaria |
3.5% |
Ventricular Tachycardia |
3.5% |
Weight Decreased |
3.5% |
Abdominal Distension |
2.4% |
Back Pain |
2.4% |
Benign Ovarian Tumour |
2.4% |
Breast Cancer |
2.4% |
Cardiomyopathy |
2.4% |
Drug Ineffective |
2.4% |
|
Interacting |
Pain |
21.4% |
Type 2 Diabetes Mellitus |
21.4% |
Arthralgia |
14.3% |
Spinal Compression Fracture |
14.3% |
Hypertension |
7.1% |
Peripheral Artery Bypass |
7.1% |
Product Used For Unknown Indication |
7.1% |
Thrombosis |
7.1% |
|
Hypertensive Crisis |
25.0% |
Melaena |
25.0% |
International Normalised Ratio Increased |
12.5% |
Renal Failure Acute |
12.5% |
Syncope |
12.5% |
Vision Blurred |
12.5% |
|